Stratasys Enrolls First Patient In Clinical Study To Assess3D Printed Models For Orthopedic Tumor Removal
Portfolio Pulse from Benzinga Newsdesk
Stratasys and Ricoh have initiated a clinical study to evaluate the effectiveness of 3D printed models compared to traditional CT or MRI scans for planning bone tumor excisions. The first patient has been enrolled in this study.
June 26, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stratasys has started a clinical study with Ricoh to evaluate 3D printed models for bone tumor excision planning, enrolling the first patient.
The initiation of a clinical study and the enrollment of the first patient highlight Stratasys' commitment to innovation in medical applications. This could positively impact investor sentiment and drive short-term stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100